DK / 5 Broker-Friendly Stocks to Monitor Amid Current Uncertainty

Delek US Holdings (DK) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a like more_horizontal

Delek US (DK) plans to spend $350 million on capital expenditures for 2023, including $202 million for Refining, $81 million for Logistics, $31 millio more_horizontal

While the top- and bottom-line numbers for Delek US Holdings (DK) give a sense of how the business performed in the quarter ended June 2023, it could more_horizontal

Delek US Holdings (DK) came out with quarterly earnings of $1 per share, beating the Zacks Consensus Estimate of $0.66 per share. This compares to ear more_horizontal

BRENTWOOD, Tenn. , July 11, 2023 /PRNewswire/ -- Delek US Holdings, Inc. (NYSE: DK) ("Delek US") today announced that the Company intends to issue a p more_horizontal

BRENTWOOD, Tenn. , July 11, 2023 /PRNewswire/ -- Delek Logistics Partners, LP (NYSE: DKL) ("Delek Logistics") today announced that the Partnership int more_horizontal

The hit Wegovy weight-loss drug is on track for sales of over $4 billion this year in the U.S. alone, despite its manufacturer Novo Nordisk struggling more_horizontal

Delek US (DK) projects $350 million in capital expenditures for the full-year 2023. It expects to spend $202 million on Refining, $81 million on Logis more_horizontal